Béatrice De Vos

3.8k total citations
22 papers, 1.4k citations indexed

About

Béatrice De Vos is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Animal Science and Zoology. According to data from OpenAlex, Béatrice De Vos has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Animal Science and Zoology. Recurrent topics in Béatrice De Vos's work include Viral gastroenteritis research and epidemiology (18 papers), Viral Infections and Immunology Research (15 papers) and Animal Virus Infections Studies (8 papers). Béatrice De Vos is often cited by papers focused on Viral gastroenteritis research and epidemiology (18 papers), Viral Infections and Immunology Research (15 papers) and Animal Virus Infections Studies (8 papers). Béatrice De Vos collaborates with scholars based in Belgium, United Kingdom and South Africa. Béatrice De Vos's co-authors include A. Delem, Timo Vesikari, Aino Karvonen, Irene Pérez‐Schael, Guillermo M. Ruiz‐Palacios, Alexandre C. Linhares, Alain Bouckenooghe, Htay Htay Han, Kong Boo Phua and Paul Gillard and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Vaccine.

In The Last Decade

Béatrice De Vos

21 papers receiving 1.4k citations

Peers

Countries citing papers authored by Béatrice De Vos

Since Specialization

Citations

This map shows the geographic impact of Béatrice De Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Béatrice De Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Béatrice De Vos more than expected).

Fields of papers citing papers by Béatrice De Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Béatrice De Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Béatrice De Vos. The network helps show where Béatrice De Vos may publish in the future.

Co-authorship network of co-authors of Béatrice De Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Béatrice De Vos. A scholar is included among the top collaborators of Béatrice De Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Béatrice De Vos. Béatrice De Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extracellular Vesicles: A New Promise for the Prevention of Bronchopulmonary Dysplasia 2022 ·American Journal of Perinatology ·Luca Bonadies, Béatrice De Vos, Maurizio Muraca, Eugenio Baraldi	0
2	Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations 2019 ·Vaccine ·Johan Vekemans, Michael J. Brennan, Mark Hatherill, Lewis K. Schrager, Bernard Fritzell, Kathryn Rutkowski, Béatrice De Vos, Matteo Zignol, Georges Thiry, Ann M. Ginsberg, Barry Walker	18
3	Comparison of 2 Different Regimens for Reactogenicity, Safety, and Immunogenicity of the Live Attenuated Oral Rotavirus Vaccine RIX4414 Coadministered with Oral Polio Vaccine in South African Infants 2010 ·The Journal of Infectious Diseases ·A. Duncan Steele, (unknown), (unknown), P.K. Bos, M. C. de Beer, John Tumbo, C.F. van der Merwe, A. Delem, Béatrice De Vos	39
4	Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa 2010 ·The Pediatric Infectious Disease Journal ·A. Duncan Steele, Shabir A. Madhi, Cheryl Louw, P.K. Bos, John Tumbo, (unknown), (unknown), Béatrice De Vos, A. Delem, Htay Htay Han	47
5	Live Attenuated Human Rotavirus Vaccine, RIX4414, Provides Clinical Protection in Infants Against Rotavirus Strains With and Without Shared G and P Genotypes 2009 ·The Pediatric Infectious Disease Journal ·Béatrice De Vos, Htay Htay Han, Alain Bouckenooghe, S. Debrus, Paul Gillard, Richard L. Ward, Brigitte Cheuvart	63
6	A Review of Rotavirus Infection in and Vaccination of Human Immunodeficiency Virus–Infected Children 2009 ·The Journal of Infectious Diseases ·A. Duncan Steele, Nigel A. Cunliffe, John Tumbo, Shabir A. Madhi, Béatrice De Vos, Alain Bouckenooghe	25
7	Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines 2008 ·Vaccine ·A. Duncan Steele, Béatrice De Vos, John Tumbo, (unknown), (unknown), P.K. Bos, M. C. de Beer, C.F. van der Merwe, A. Delem	85
8	Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study 2008 ·The Lancet ·Alexandre C. Linhares, F. Raúl Velázquez, Irene Pérez‐Schael, Xavier Sáez‐Llorens, Héctor Abate, Félix Espinoza, Pío López, Mercedes Macías-Parra, Eduardo Ortega‐Barría, Doris Maribel Rivera-Medina, Luis Rivera, Noris Pavía-Ruz, Ernesto Martín Núñez, Silvia Damaso, Guillermo M. Ruiz‐Palacios, Béatrice De Vos, Miguel O’Ryan, Paul Gillard, Alain Bouckenooghe	307
9	Evaluation of Circulating Intestinally Committed Memory B Cells in Children Vaccinated with Attenuated Human Rotavirus Vaccine 2007 ·Viral Immunology ·Olga L. Rojas, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carlos F. Narváez, Juan Manuel Lozano, Béatrice De Vos, M. Franco, Juana Ángel	33
10	Intussusception Among Young Children in Europe 2006 ·The Pediatric Infectious Disease Journal ·Hans-Iko Huppertz, Montse Soriano‐Gabarró, E. Grimprel, Elisabetta Franco, (unknown), Ulrich Desselberger, Yolba Smit, (unknown), Béatrice De Vos, Carlo Giaquinto	103
11	A short report on highlights of worldwide development of RIX4414: A Singaporean experience 2006 ·Vaccine ·Kong Boo Phua, Seng Hock Quak, S C Emmanuel, P. Goh, Htay Htay Han, Karin Hardt, H.L. Bock, Béatrice De Vos	9
12	A short report on highlights of world-wide development of RIX4414: A Latin American experience 2005 ·Vaccine ·A. C. Linhares, Guillermo M. Ruiz‐Palacios, M. Lourdes Guerrero, Beatriz Salinas, Irene Pérez‐Schael, Sue Ann Costa Clemens, Bruce L. Innis, Juan Pablo Yarzábal, G N R Vespa, Yolanda Cervantes, Karin Hardt, Béatrice De Vos	23
13	A short report on highlights of world-wide development of RIX4414: An European experience 2005 ·Vaccine ·Timo Vesikari, Aino Karvonen, Leena Puustinen, (unknown), Shang‐Qin Zeng, A. Delem, Béatrice De Vos	7
14	A short report on clinical evaluation of RIX4414: highlights of world-wide development 2005 ·Vaccine ·Béatrice De Vos, A. Delem, Karin Hardt, H.L. Bock, François Meurice, Bruce L. Innis	9
15	Evaluation of RIX4414, A Live, Attenuated Rotavirus Vaccine, in a Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial Involving 2464 Singaporean Infants 2005 ·The Journal of Infectious Diseases ·Kong Boo Phua, Seng Hock Quak, Bee Wah Lee, Shanta Emmanuel, P. Goh, Htay Htay Han, Béatrice De Vos, Hans L. Bock	99
16	Comparative Evaluation of Safety and Immunogenicity of Two Dosages of an Oral Live Attenuated Human Rotavirus Vaccine 2005 ·The Pediatric Infectious Disease Journal ·Penelope H. Dennehy, Rebecca C. Brady, Scott A. Halperin, Richard L. Ward, Justin Alvey, (unknown), Bruce L. Innis, (unknown), Anne Schuind, Béatrice De Vos	78
17	Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants 2004 ·Vaccine ·Timo Vesikari, Aino Karvonen, Tiina Korhonen, Merimaaria Espo, E. Lebacq, Johannes Förster, Fred Zepp, A. Delem, Béatrice De Vos	112
18	A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis 2004 ·The Pediatric Infectious Disease Journal ·Béatrice De Vos, Timo Vesikari, Alexandre C. Linhares, Belén Salinas, Irene Pérez‐Schael, Guillermo M. Ruiz‐Palacios, (unknown), Kong Boo Phua, A. Delem, Karin Hardt	124
19	Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants 2004 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, Leena Puustinen, Shang‐Qin Zeng, (unknown), A. Delem, Béatrice De Vos	164
20	Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation. 1995 ·PubMed ·K Atkinson, Béatrice De Vos, (unknown), (unknown), Robert M. Seymour, Steven Gillis	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact